CSIMarket


Celularity Inc   (CELU)
Other Ticker:  
 
 

CELU's Revenue Growth by Quarter and Year

Celularity Inc 's Revenue results by quarter and year




CELU Revenue (in millions $) FY 2021 FY 2020 FY 2019 FY 2018
IV Quarter December - 0.00 0.00 0.00
III Quarter September 10.62 0.00 0.00 0.00
II Quarter June - 0.00 0.00 0.00
I Quarter March 0.00 0.00 0.00 0.00
FY   10.62 - - -



CELU Revenue third quarter 2021 Y/Y Growth Comment
Celularity Inc in the third quarter achieved Revenue of $ 10.62 millions compare to recorded in same quarter a year ago.

According to the results reported in the third quarter, Celularity Inc achieved the best Revenue growth in Major Pharmaceutical Preparations industry. While Celularity Inc ' s Revenue no change of % ranks overall at the positon no. 0 in the third quarter.




CELU Revenue ( Y/Y Growth %) 2021
2020 2019 2018
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Celularity Inc 's third quarter 2021 Revenue $ 10.62 millions CELU's Income Statement
Celularity Inc 's third quarter 2020 Revenue $ 0.00 millions Quarterly CELU's Income Statement
New: More CELU's historic Revenue Growth >>


CELU Revenue (Quarter on Quarter Growth %)

2021
2020 2019 2018
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - - -




Revenue third quarter 2021 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #0

Revenue Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Revenue third quarter 2021 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #0
Revenue Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Revenue by Quarter for the Fiscal Years 2018, 2019, 2020, 2021

Celularity Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


CELU's III. Quarter Q/Q Revenue Comment


Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #0
Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #0
Revenue Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


CELU's III. Quarter Q/Q Revenue Comment


Celularity Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Sep 30 2021)
12 Months Ending
(Jun 30 2021)
12 Months Ending
12 Months Ending
12 Months Ending
Cumulative Revenue 12 Months Ending $ 0.00 $ 0.00 $ 0.00 $ 0.00 $ 0.00
Y / Y Revenue Growth (TTM) - - - - -
Year on Year Revenue Growth Overall Ranking # # # # #
Seqeuential Revenue Change (TTM) - - - - -
Seq. Revenue Growth (TTM) Overall Ranking # # # # #




Cumulative Revenue growth Comment
In the Sep 30 2021 period, Celularity Inc 's cumulative trailing twelve month Revenue remained unchanged compare to the same period a year ago.

Celularity Inc achieved highest trailing twelve month year on year Revenue growth. While overall Revenue growth ranking, remained unchanged compare to the previous quarter at no. .

Revenue TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Revenue TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Revenue growth Comment
In the Sep 30 2021 period, Celularity Inc 's cumulative trailing twelve month Revenue remained unchanged compare to the same period a year ago.

Celularity Inc achieved highest trailing twelve month year on year Revenue growth. While overall Revenue growth ranking, remained unchanged compare to the previous quarter at no. .

Revenue TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Revenue TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Revenue Growth
Major Pharmaceutical Preparations Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
CELU's Revenue Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for CELU's Competitors
Revenue Growth for Celularity Inc 's Suppliers
Revenue Growth for CELU's Customers

You may also want to know
CELU's Annual Growth Rates CELU's Profitability Ratios CELU's Asset Turnover Ratio CELU's Dividend Growth
CELU's Roe CELU's Valuation Ratios CELU's Financial Strength Ratios CELU's Dividend Payout Ratio
CELU's Roa CELU's Inventory Turnover Ratio CELU's Growth Rates CELU's Dividend Comparisons



Companies with similar Revenue no change for the quarter ending Sep 30 2021 within Healthcare SectorY/Y Change %Revenue for the quarter ending Sep 30 2021
Enanta Pharmaceuticals Inc-0.24%$ -0.237 millions
Zimmer Biomet Holdings Inc -0.27%$ -0.275 millions
Community Health Systems Inc -0.35%$ -0.352 millions
Quest Diagnostics Inc-0.43%$ -0.431 millions
Twinlab Consolidated Holdings Inc -0.54%$ -0.539 millions
Repro Med Systems Inc -0.65%$ -0.654 millions
Avanos Medical Inc -0.86%$ -0.862 millions
Cytomx Therapeutics Inc -1.13%$ -1.130 millions
Bausch Health Companies Inc -1.26%$ -1.263 millions
Xtant Medical Holdings Inc -1.71%$ -1.705 millions
Mimedx Group Inc -1.91%$ -1.911 millions
Clovis Oncology inc -2.21%$ -2.208 millions
Teva Pharmaceutical Industries Ltd-2.29%$ -2.288 millions
Aziyo Biologics inc -2.45%$ -2.455 millions
Alimera Sciences Inc -2.57%$ -2.566 millions
Nuwellis Inc -2.68%$ -2.679 millions
Pressure Biosciences Inc -2.90%$ -2.903 millions
Lifevantage Corp-2.92%$ -2.924 millions
Immunitybio inc -2.94%$ -2.941 millions
Fitlife Brands Inc -3.15%$ -3.149 millions
Luna Innovations Inc-3.43%$ -3.425 millions
Cardiovascular Systems Inc -3.59%$ -3.591 millions
Vyant Bio Inc -3.95%$ -3.954 millions
Hologic Inc-4.28%$ -4.279 millions
Supernus Pharmaceuticals inc -4.30%$ -4.300 millions
Procyon Corp-4.51%$ -4.515 millions
Healthcare Services Group Inc -4.67%$ -4.670 millions
Star Equity Holdings Inc -4.92%$ -4.922 millions
Ayala Pharmaceuticals Inc -5.02%$ -5.015 millions
Recro Pharma Inc -5.44%$ -5.444 millions


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

CENQ's Profile

Stock Price

CENQ's Financials

Business Description

Fundamentals

Charts & Quotes

CENQ's News

Suppliers

CENQ's Competitors

Customers & Markets

Economic Indicators

CENQ's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071